✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Glaukos Corp

Common Name
Glaukos
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
995
Ticker
GKOS
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Glaukos Corporation is a medical technology company dedicated to the development and commercialization of innovative products for the treatment of glaucoma, corneal disorders, and retinal diseases. It...

Disclosures of Glaukos

Explore Glaukos's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Glaukos's official channels and fully traceable to its official company sources.

The table below lists all of Glaukos's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Glaukos's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
10-K
2024
Financial & Extra-Financial Disclosure
2024
Sustainability Report
2024
10-K
2023
Sustainability Report
2023
Financial & Extra-Financial Disclosure
2023
10-K
2022
Sustainability Report
2022
10-K
2021
Sustainability Report
2021
Financial & Extra-Financial Disclosure
2021
10-K
2020
Sustainability Report
2020
Financial & Extra-Financial Disclosure
2020
Equal employment opportunity (EEO) Report
2020
10-K
2019
Sustainability Report
2019
10-K
2018
Financial & Extra-Financial Disclosure
2018
10-K
2017
Financial & Extra-Financial Disclosure
2017
10-K
2016
Financial & Extra-Financial Disclosure
2016
10-K
2015
Financial & Extra-Financial Disclosure
2015
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?